Abstract
Both calcium and vitamin D play important roles in cardiac muscle contraction and performance. In this cross-sectional study, we evaluated the status of serum calcium, PTH and 25(OH)D3 and their correlation with left ventricular Function and NYHA Functional class in 95 heart failure patients referred to Shahid Chamran Hospital, Isfahan, Iran, by colorimetric, immunoradiometric, and Immunochemiluminescent assays, echocardiography and interview respectively. The study was performed between Oct 2007 and Feb 2008. Twenty eight women and 67 men of functional classes 1, 2, or 3 participated in the study. Mean (SD) of age of the participants was 62(11) years. Mean (SD) serum calcium and 25(OH)D3 were 2.41(0.16) mmol/L and 56.78(51.33) nmol/L, respectively. The overall prevalence of low vitamin D status was 84.2%. There was no correlation between serum calcium and 25(OH)D3 with LVEF. Interestingly, patients with hyperparathyroidism (serum PTH>65 ng/L) had lower LVEF (27% versus 32.5% p = 0.03). NYHA functional class was worse in patients with hyperparathyroidism (p = 0.08). Hypovitaminosis D is very prevalent in heart failure patients. Hyperparathyroidism in these patients may adversely affect cardiac function. Vitamin D3 might serve as an adjunctive treatment for heart failure patients.
Similar content being viewed by others
References
Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25:1614–1619
Loehr LR, Rosamond WD, Chang PP, Folsom AR, Chambless LE (2008) Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 101:1016–1022
Curtis LH, Greiner MA, Hammill BG, Kramer JM, Whellan DJ, Schulman KA, Hernandez AF (2008) Early and long-term outcomes of heart failure in elderly persons, 2001–2005. Arch Intern Med 168:2481–2488
Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS (1998) Hypovitaminosis D in medical inpatients. N Engl J Med 338:777–783
Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC (2005) Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin–angiotensin systems. Am J Physiol Endocrinol Metab 288:E125–E132
Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J (2004) Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90:387–392
Alsafwah S, Laguardia SP, Arroyo M, Dockery BK, Bhattacharya SK, Ahokas RA, Newman KP (2007) Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res 5:238–243
Newman KP, Neal MT, Roberts M, Goodwin KD, Hatcher EA, Bhattacharya SK (2007) The importance of lost minerals in heart failure. Cardiovasc Hematol Agents Med Chem 5:295–299
Laguardia SP, Dockery BK, Bhattacharya SK, Nelson MD, Carbone LD, Weber KT (2006) Secondary hyperparathyroidism and hypovitaminosis D in African–Americans with decompensated heart failure. Am J Med Sci 332:112–118
Khouzam RN, Dishmon DA, Farah V, Flax SD, Carbone LD, Weber KT (2006) Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci 331:30–34
Nibbelink KA, Tishkoff DX, Hershey SD, Rahman A, Simpson RU (2007) 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol 103:533–537
Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ (2008) Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 102:1540–1544
The Criteria Committee of the New York Heart Association (1994) Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. Little Brown, Boston
Witte KK, Clark AL (2006) Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives. Heart Fail Rev 11:65–74
Zittermann A, Schleithoff SS, Koerfer R (2006) Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 11:25–33
Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P (2003) Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41:105–112
Haug CJ, Aukrust P, Haug E, Morkrid L, Muller F, Froland SS (1998) Severe deficiency of 1, 25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 83:3832–3838
Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R (2006) Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 83:754–759
Zittermann A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94:483–492
Halapas A, Diamanti-Kandarakis E, Kremastinos D, Koutsilieris M (2006) The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: possible therapeutic implications. In Vivo 20:837–844
Dastur DK, Gagrat BM, Wadia NH, Desai M, Bharucha EP (1975) Nature of muscular change in osteomalacia: light- and electron-microscope observations. J Pathol 117:211–228
Selles J, Boland R (1991) Evidence on the participation of the 3', 5'-cyclic AMP pathway in the non-genomic action of 1, 25-dihydroxy-vitamin D3 in cardiac muscle. Mol Cell Endocrinol 82:229–235
Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU (2007) Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol 103:416–419
Grayburn PA, Appleton CP, DeMaria AN, Greenberg B, Lowes B, Oh J, Plehn JF, Rahko P, St John SM, Eichhorn EJ (2005) Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol 45:1064–1071
Frost RJ, Sonne C, Wehr U, Stempfle HU (2007) Effects of calcium supplementation on bone loss and fractures in congestive heart failure. Eur J Endocrinol 156:309–314
McGonigle RJ, Fowler MB, Timmis AB, Weston MJ, Parsons V (1984) Uremic cardiomyopathy: potential role of vitamin D and parathyroid hormone. Nephron 36:94–100
McCarty MF (2005) Nutritional modulation of parathyroid hormone secretion may influence risk for left ventricular hypertrophy. Med Hypotheses 64:1015–1021
Rostand SG, Drueke TB (1999) Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 56:383–392
Acknowledgments
The authors are grateful both to Dr. Golestanfar and Sattari from Pars medical laboratories for their kind help and the patients who participated in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garakyaraghi, M., Kerdegari, M. & Siavash, M. Calcium and Vitamin D Status in Heart Failure Patients in Isfahan, Iran. Biol Trace Elem Res 135, 67–73 (2010). https://doi.org/10.1007/s12011-009-8492-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-009-8492-9